Please wait

 

Calculation of Filing Fee Tables

 

Form 424(b)(5)

(Form Type)

 

Perspective Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee(1)(7)(8)

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common Stock, $0.001 par value per share

Rule 456(b) and Rule 457(r)

51,515,880

$1.51

$79,999,999

.0001476

$11,808

-

-

-

-

Fees to Be Paid

Equity

Pre-funded warrants to purchase common stock

Rule 456(b) and Rule 457(r)

1,464,252

$1.509

---(2)

.0001476

---(2)

Fees Previously Paid

-

-

-

-

-

Carry Forward Securities

Carry

Forward Securities

-

N/A

-

-

N/A

N/A

N/A

N/A

Total Offering Amounts

-

$79,999,999

-

$11,808

-

-

-

-

Total Fees Previously Paid

-

-

-

-

-

-

-

-

Total Fee Offsets

-

-

$11,808(3)

-

-

-

-

Net Fee Due

-

-

$0

-

-

-

-

 

 

Table 2: Fee Offset Claims and Sources

 

 

Registrant or Filer Name

Form or Filing Type

File Number

Initial Filing Date

Filing Date

Fee Offset Claimed

 

 

 

Security Type Associated with Fee Offset Claimed

 

 

 

Security Title Associated with Fee Offset Claimed

 

 

Unsold Securities Associated with Fee Offset Claimed

 

 

Unsold Aggregate Offering Amount Associated with Fee Offset Claimed

 

 

Fee Paid With Fee Offset Source

Rule 457(p)

Fees Offset Claims

Perspective Therapeutics, Inc.

S-3

333-275638

11/17/2023

-

$11,973(3)

Unallocated (Universal) Shelf

(3)

(3)

$81,123,644

-

Fees Offset Sources

Perspective Therapeutics, Inc.

S-3

333-275638

-

11/17/2023

-

-

-

-

-

(3)

 

(1)
Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). Payment of the registration fee at the time of filing of the registrant’s Registration Statement on Form S-3 (File No. 333-279692) on May 23, 2024 was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act and is paid herewith. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering.
(2)
Represents the sum of the pre-funded warrants sales price of $1.509 per pre-funded warrant and the exercise price of $0.001 per share issuable pursuant to the pre-funded warrants. Pursuant to the Securities and Exchange Commission staff interpretation, the entire fee is allocated to the common stock underlying the pre-funded warrants.
(3)
The registrant previously registered an indeterminate amount of securities having an aggregate offering price of up to $200,000,000 pursuant to a Registration Statement on Form S-3 No. 333-275638, filed on November 17, 2023 and amended on December 7, 2023 (the “2023 Registration Statement”), and paid a total registration fee of $29,520 on the registration of $200,000,000 newly registered securities thereunder. The Registrant sold an aggregate of $118,876,356 of such

 

 

 

securities under the 2023 Registration Statement, leaving the balance of $81,123,644 (the “2023 Unsold Securities”), representing $11,973 in registration fees, of such 2023 Unsold Securities under the 2023 Registration Statement. Pursuant to Rule 457(p) under the Securities Act, such unutilized filing fees may be applied to the filing fees payable pursuant to this Registration Statement. The offering of such 2023 Unsold Securities from the 2023 Registration Statement has been terminated.